Rotavirus Infections — A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine
Citation(s)
A Phase II Randomized, Double Blind, Parallel Group Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine Administered at a High, Mid and Low Titre as a 3 Dose Neonate Schedule or Administered at a High Titre as a 3 Dose Infant Schedule.